GLAND PHARMA NEWS

The Nifty Pharma index closed 1.13 per cent up at 20844.55.

The Nifty Pharma index was trading 1.02 per cent up at 20822.85.

The Nifty Pharma index closed 0.05 per cent up at 20612.65.

The Nifty Pharma index was trading 0.17 per cent down at 20566.55.

The Nifty Pharma index closed 0.6 per cent down at 20601.7.

The Nifty Pharma index closed 0.39 per cent up at 20725.95.

The Nifty Pharma index closed 1.57 per cent up at 20645.8.

The Nifty Pharma index was trading 0.24 per cent up at 20373.6.

The Nifty Pharma index closed 0.63 per cent down at 20325.8.

Indian stock markets hit a milestone with record block deals worth ₹23,000 crore, driven by Vodafone Group's stake sale in Indus Towers.

Shares of Delta Corp, the sole listed company in India's casino gaming industry, saw a significant surge of nearly 15%. This increase in stock price came amidst expectations that the Goods and Services Tax (GST) Council might review the tax structur...

Domestic markets start positively with Paytm, Indus Towers, Vedanta, Cipla, Gland Pharma in focus. ZEE appoints acting CFO. Tata Technologies partners with Microsoft. Wabco to sell ZF equity. Craftsman Automation launches QIP. Fosun Pharma reduces s...

The listed arm of billionaire Guo Guangchang’s Fosun International Ltd. holds about 58% of Gland Pharma, which has a market value 303 billion rupees ($3.6 billion). It will carry out more block sales in the coming months to shore up its balance shee...

Grasim Ltd, part of the Aditya Birla Group, reported 39% growth in its consolidated net profit (excluding exceptional item) at Rs 1,908 crore for the quarter ended March 2024.

HDFC Mid-Cap Opportunities Fund's transactions in 20 stocks during January-March quarter included buying shares in Ipca Laboratories, Max Financial Services, and Adani Group owned ACC. It also added shares in Timken India, Mahindra & Mahindra Financ...

Shares of Gland Pharma dropped 6% to Rs 1,745 on BSE as entities related to ex-promoter Dr Ravi Penmetsa sold 5.5% equity. Large block deals of 91 lakh shares worth Rs 1,600 crore reported.

Two entities – Nicomac Machinery and RP Advisory Services – are likely to sell upto 4.4% stake in Gland Pharma through block deals on Tuesday, according to news reports.

Nicomac Machinery and RP Advisory Services ​are looking at raising Rs 1,400 crore through the sale, and have set the floor price for the same at Rs 1,725/share. The floor price is at a discount of over 7% to the current market price of the stock. On...

The Board of Nestle India approved paying a royalty fee to its parent company Nestle S.A. The payment will be made at a rate of up to 5.25% of total net sales and it is payable in a staggered manner over five years.